On an earnings call with analysts this week, Boston Scientific (NYSE:BSX) CEO Mike Mahoney touted the momentum of his company’s drug-eluting stent portfolio but noted that the technologies continue to face headwinds in the U.S. thanks to pricing pressure. The Mass.-based company reported third-quarter profits of $432 million, or 31¢ per share, on sales of $2.39 billion […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Hahn Group acquires Rethink Robotics IP
We have not seen the last of Sawyer the collaborative robot. Hahn Group, a German automation specialist, has acquired all of the patents and trademarks from Rethink Robotics, including the Intera 5 software platform. The Hahn Group says it will further develop Rethink’s technology, “combining it with German engineering and know-how of industrial applications.” Hahn Group says it “intends […]
NovoCure slides on Q3 sales miss
NovoCure (NSDQ:NVCR) shares took a hit today, despite lower-than-forecast losses, after the company reported financial results that missed expectations for third-quarter sales. Losses were up 1.7% to -$11.7 million, or -13¢ per share, on sales growth of 29.2% to $64.8 million for the three months ended Sept. 30, compared with Q3 2017. The consensus estimate on Wall […]
Align Tech shares tumble despite Q3 EPS beat
Shares in Align Technology (NSDQ:ALGN) have tumbled over 20% today after the orthodontic device maker posted downbeat guidance alongside third quarter earnings that beat The Street. The San Jose, Calif.-based company posted profits of approximately $100.9 million, or $1.24 per share, on sales of approximately $505.3 million for the three months ended September 30, seeing profits […]
Endologix launches $20m offering
Endologix (NSDQ:ELGX), looking to refinance its debt, said it’s floating $20 million worth of its own shares in a public offering. The Irvine, Calif.-based stent graft maker said the offering also includes a 30-day underwriter’s option worth another $3 million. Endologix said it plans to use the proceeds to pay off $18.3 million worth of 2.25% […]
LumiThera inks distro deal with Nikon’s Optos
LumiThera said today it inked a distribution deal with Nikon (TYO:7731) subsidiary Optos to distribute its Valeda light delivery system intended for use in treating dry age-related macular degeneration. The deal will position Optos as the exclusive distributor of the device in 12 European countries, the Seattle-based company said. The device has already won CE Mark approval in the […]
ICU Medical warns about leaks in Thermoset drug-delivery systems
ICU Medical (NSDQ:ICUI) issued a warning this month that it received reports of leakage with some lots of its Thermoset drug-delivery systems in Europe, the Middle East and Africa. The company noted that the affected Thermoset products included its room-temperature closed-loop drug-delivery system with an in-line temperature probe, as well as its Iced Thermoset system designed […]
Teleflex’s NeuroTract touts UK Urolift decision
Teleflex (NYSE:TFX) subsidiary NeoTract said today that the UK Government selected the UroLift system, intended to treat patients with benign prostatic hyperplasia, as one of seven Accelerated Access Collaborative “Rapid Uptake Products.” The Wayne, Penn.-based company said that the system will now receive support from the Accelerated Access Collaborative which will increase its use by the UK’s NHS. […]
Novel machine-learning methodology refines simulation of heart anatomy and function
A rapid optimization technique for mitral-valve modeling is applicable to other cardiac structures. Reza Salari, Thornton Tomasetti Applied Science The medical device industry is making great strides in finite element analysis (FEA), a fundamental tool underlying simulation-guided product development. FEA enables evaluation and prediction of the behavior of implanted medical devices and their interactions with […]
Natus takes a hit on Q3 misses
Investors pushed share prices down today for Natus Medical (NSDQ:BABY) after the neonatal care company missed expectations with its third-quarter results. Pleasanton, Calif.-based Natus pared its losses by -34.5% to -$5.6 million, or -17¢ per share, on sales growth of 6.5% to $130.6 million for the three months ended Sept. 30, compared with Q3 2017. […]
Varian shares rise on Q4 sales beat
Shares in Varian Medical (NYSE:VAR) have risen today after the company posted fourth quarter results that beat The Street’s sales expectations, but narrowly missed earnings per share consensus. The Palo Alto, Calif.-based company posted profits of $116.8 million, or $1.26 per share, on sales of $801.6 million for the three months ended September 28, seeing the […]